Home
|
Show All
|
Simple Search
|
Advanced Search
Login Admin Infodrog
Quick Search:
Field:
main fields
author
title
publication
year
keywords
publisher
call_number
notes
contains:
1–1 of 1 record found matching your query (
RSS
):
Search & Display Options
Search within Results:
Field:
author
title
year
keywords
abstract
type
publication
abbrev_journal
volume
issue
pages
thesis
publisher
place
editor
series_title
language
area
notes
call_number
serial
contains:
Exclude matches
Display Options:
Field:
all fields
keywords & abstract
additional fields
records per page
Select All
Deselect All
<<
1
>>
List View
|
Citations
|
Details
Record
Links
Author
Dalgard, O.; Bjøro, K.; Hellum, K.; Myrvang, B.; Skaug, K.; Gutigard, B.; Bell, H.
Title
Treatment of Chronic Hepatitis C in Injecting Drug Users: 5 Years' Follow-Up
Type
Journal Article
Year
2002
Publication
European addiction research
Abbreviated Journal
Volume
8
Issue
Pages
45-49
Keywords
health promotion; viral hepatitis; hepatitis C
Abstract
Aim of the Study: To assess the long-term hepatitis C (HCV) treatment outcome in former injecting drug users (IDUs). Materials and Methods: A long-term follow-up of 27 former IDUs who had been successfully treated for chronic hepatitis C was performed. These patients represented ailiDUs who had obtained a sustained virological response in a Norwegian HCV treatment trial. The patients had been treated with interferon-a alone or in combinatlon with ribavirin. At 5 years’ follow-up the 27 IDUs were retested for HCV RNA and risk behaviour for HCV transmission after treatment was assessed. In the control group ail 18 non-IDUs who had obtained a sustained virological response in the same treatment trial were included. Results: At follow-up 13-82 months (median 64) after the end of treatment only one case of probable reinfection was seen among the 27 IUDs. No reoccur- rence of HCV was observed in the control group. The IDU who was HCV RNA positive at follow-up had continued injecting drugs and reported frequent needle sharing. At follow-up HCV of genotype 1a was detected in contrast to genotype 1b before treatment indicating that this patient was reinfected with HCV. A return to injecting drug use occurred in 9 (33%) of 27 IDUs. Conclusion: The long-term outcome of HCV treatment in former IDUs was excellent. Despite frequent reinitiation of drug injection ail but 1 remained HCV RNA negative.
Address
Corporate Author
Thesis
Publisher
Place of Publication
Editor
Language
English
Summary Language
Original Title
Series Editor
Series Title
Abbreviated Series Title
Series Volume
Series Issue
Edition
ISSN
ISBN
Medium
Area
Expedition
Conference
Notes
Approved
no
Call Number
50-02733
Serial
59741
Permanent link to this record
Select All
Deselect All
<<
1
>>
List View
|
Citations
|
Details
Home
Show Record
|
Extract Citations